![]() |
|
|||||||||||||||||||||||||||
| News and Press Releases | |||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
|
President John Murphy to Discuss Trends and Opportunities in the Optoelectronics Industry - See PerkinElmer at Photonics West 2004 in Booth 614 Fremont, CA -- January 20,2004 -- PerkinElmer Optoelectronics, a global technology leader providing market-driven integrated solutions for biomedical and industrial applications, today announced that it will present at OE Magazine's 2004 Photonics Market Opportunities Forum entitled "Show Me the Money." The presentation will take place in conjunction with Photonics West 2004, on January 28, 2004 at 2:45 PM, at the San Jose Convention Center in San Jose, California. The forum will provide attendees with snapshots into hot market areas, trends in funding and research, and technologies required for growth in the photonics industry. John P. Murphy, president of PerkinElmer Optoelectronics, will speak on "Optoelectronics: Fueling the Medical, Genomic, and Digital Revolutions." Mr. Murphy will offer insights into current trends and opportunities in the biomedical and industrial markets, and share practical business solutions for bringing technology to market and driving profitable growth. For example, Mr. Murphy will offer business development tips such as
how to drive a clear product strategy and organize for success by focusing
on key markets and applications - as well as case studies on developing
leading edge optoelectronics technologies and markets. Highlights include:
PerkinElmer will be showcasing its amorphous silicon digital X-Ray detectors, CCD cameras and detectors, spectrometers, flash lamps, smart sensors, and Cermax Xenon lamps at Photonics West 2004 in booth 614. Factors Affecting Future Performance This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) fluctuations in the global economic and political environments; (4) markets into which we sell our products decline or do not grow as anticipated; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials and supplies; (11) our ability to produce an adequate quantity of products to meet our customers' demands; (12) the manufacture and sale of products may expose us to product liability claims; (13) our failure to maintain compliance with applicable government regulations; (14) regulatory changes; (15) our failure to comply with health care industry regulations; (16) economic, political and other risks associated with foreign operations; (17) our ability to retain key personnel; (18) restrictions in our credit agreements; (19) our ability to realize the full value of our intangible assets; (20) significant fluctuations in our stock price; and (21) other factors which we describe under the caption "Risk Factors" in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release. About PerkinElmer, Inc. PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2 billion in 2008, has around 8,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.
|
|||||||||||||||||||||||||||
| North America: +1 800-775-OPTO [6786] Europe: +49 611 492 430 Asia: +65 6775 2022 |
| Contact Us | Site Map | Terms and Conditions | Privacy Policy |
| Copyright 1998-2004. PerkinElmer, Inc. All rights reserved. |